Underweight LRCX: Trim 30-40% to reduce near-term risk while preserving core exposure for potential breakout
Underweight rating stands with 30-40% trim executed in tranches; target $300 over 3-6 months contingent on October earnings catalyst review; upgrade to Hold or Overweight warranted on wide beat/guidance above ~$11.56 forward EPS or confirmed closes above $370 with required volume and moving average reclaim.
| Position | Action |
|---|---|
| Trim 30-40% of position in two evidence-based tranches | REDUCE_POSITION_30_40% |
| Sell 15-20% on confirmed push into $351-$352 above 10M volume | SELL 15-20% |
| Another 10-20% on successful test and hold of $370 | SELL 10-20% |
| Retain core position of 60-75% | HOLD_CORE_60-75% |
| Daily close below $337 on above-average volume | TRIGGER_DEFENSIVE_REVIEW |
Lam Research is a high-quality cyclical compounder with accelerating earnings, expanding margins, a 65% ROE, and a structural etch moat positioned to benefit from the memory capex supercycle and next-generation semiconductor nodes.
| Indicator | Value | Signal |
|---|---|---|
| Close | 343.84 | neutral |
| 10 EMA | 322.50 | bullish |
| 50 SMA | 337.58 | neutral |
| 200 SMA | 250.24 | bullish |
| MACD Line | 0.73 | bullish |
| MACD Signal | -5.75 | bullish |
| MACD Histogram | +6.48 | bullish |
| RSI | 57.76 | neutral |
| Bollinger Upper Band | 351.74 | neutral |
| Bollinger Middle Band | 308.23 | neutral |
| Bollinger Lower Band | 264.72 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 10 EMA reclaims 50 SMA above 12M daily volume and LRCX holds above $370 for at least 3 closes
Then: SCALE_BACK_EXPOSURE
Smart money is rotating INTO LRCX from peer AVGO, signaling differentiated conviction
↩ rebuts: “Bear case relying on peer weakness (AMAT -6%, KLA -9%) as evidence of company-specific deterioration”
EV: +$370-390 (breakdown zone), ultimately $410+ (retrace into prior range) on breakout confirmation · concedes: Macro headwinds are real: 30-year Treasury at 19-year high, 85% odds of no Fed cuts in 2026; TTM P/E of 59.8 is elevated on current earnings; Bear concerns about punitive earnings bar have merit for the sector overall (AMAT missed expectations despite record revenue); 10 EMA still below 50 SMA (trend in transition, not confirmed uptrend); Reddit silence indicates lack of retail conviction
LRCX is a late-cycle cyclical at the top of a 499% run, with a 30x forward multiple that prices in perfect execution, facing a punitive upcoming print, macro headwinds from 19-year high yields, deteriorating cash conversion with receivables up 53% and FCF down 43% YoY, and a fragile technical setup where the 10 EMA remains below the 50 SMA on below-average volume recovery.
EV: -$94 (downside to $250 200 SMA if forward EPS comes in at $9 instead of $11.50) · concedes: AMAT reported record revenue and 51% growth guidance; The trajectory of LRCX is good/accelerating; 200 SMA held (though by only $0.26); MACD did cross bullish; 10 EMA is rising; RSI has room to run (at 56.76); The capital return program provides some floor (though slower bleed, not hard floor)
→ vs conservative: The conservative thesis of 'trust the moat, hold through the noise' ignores that 51.7% gross margin and 65.1% ROE are already priced into the 30x forward earnings multiple; holding a high-multiple stock into a binary event with 1.87 beta when fundamentals show OCF down 43% YoY is negligent, not prudent
→ vs neutral: The neutral analyst's HOLD recommendation and Druckenmiller/Gerstner 13F data argument is flawed because institutional positions were built 6-9 months ago at $250-$280; the 'smart money' is already sitting on 20-30% gains with wide mental stops, not signaling a green light to chase at $344 with 37% recovery already priced in
| neutral |
| ATR | 21.49 | neutral |
| Volume (Aug 17) | 7.78M | neutral |
Support: 250 · 308 · 322 | Resistance: 351 · 370 · 390 · 438
LRCX is in a transition phase after extreme volatility—a ~74% rally from May to June, followed by a ~42% crash, then a ~37% recovery to $343.84. Short-term momentum has turned constructive with a fresh MACD bullish crossover and RSI recovering to neutral (57.76) from oversold (31.09 on Jul 29). Price has reclaimed the 50 SMA (337.58) but remains below the critical $370–$390 breakdown zone. The 200 SMA (250.24) remains well below price, confirming long-term uptrend integrity. Overall recommendation is HOLD: tactical bullish bias on confirmed breakouts above $351.74 (Bollinger upper band) with volume >10M shares, but avoid chasing at current levels given still-elevated ATR (21.49) and lack of clean breakout confirmation.
Market Cap
$430.25B
P/E (TTM)
59.80
Forward P/E
29.75
PEG Ratio
1.55
Price/Book
34.50
Beta
1.865
Dividend Yield
0.31%
Current Ratio
2.63
TTM Revenue
$23.23B
TTM Gross Profit
$11.73B
TTM EBITDA
$8.64B
TTM Net Income
$7.27B
TTM Free Cash Flow
$3.09B
TTM ROE
65.1%
TTM ROA
22.8%
Q2 2026 Revenue
$6.72B
Q2 2026 Gross Margin
51.7%
Q2 2026 Operating Margin
37.4%
Q2 2026 Net Margin
33.9%
Q2 2026 Diluted EPS
$1.81
EPS (TTM)
$5.75
Forward EPS
$11.56
Q2 2026 Total Assets
$23.53B
Q2 2026 Stockholders' Equity
$12.47B
Q2 2026 Total Debt
$3.73B
Q2 2026 Cash & Equivalents
$5.58B
Q2 2026 Net Cash
~$1.85B
Q2 2026 Inventory
$4.28B
Q2 2026 Receivables
$5.34B
Q2 2026 Working Capital
$9.67B
Q2 2026 Operating Cash Flow
$1,457M
Q2 2026 CapEx
$189M
Q2 2026 Free Cash Flow
$1,268M
Q2 2026 Buybacks
$247M
Q2 2026 Dividends
$325M
TTM Buybacks
~$3.85B
TTM Dividends
~$1.27B
52-Week High
$438.50
52-Week Low
$94.11
50-Day MA
$337.47
200-Day MA
$249.56
Deferred Revenue
$2.28B
Strengths
Concerns
Lam Research delivered Q2 2026 revenue of $6.72B (+30.0% YoY) with TTM revenue of $23.23B and exceptional profitability metrics including 65.1% ROE, 22.8% ROA, and 31.3% net margin, supported by a net cash position of ~$1.85B and over $5B in annual capital returns through buybacks and dividends. The primary risk flagged is an elevated receivables build of +53% YoY to $5.34B (well above revenue growth), suggesting extended customer payment terms or potential shipment pull-forward that could pressure future FCF; combined with a trailing P/E of 59.80x and forward P/E of ~30x, the valuation leaves limited margin of safety if the AI/HBM capex cycle moderates or working capital trends worsen.
Macro: Risk-off macro environment with 30-year Treasury yield at 19-year high driven by heavy Treasury supply concerns and elevated oil prices. Trump threats regarding Oman and Libya pipeline developments have intensified geopolitical risk-off sentiment. Polymarket pricing implies 85% probability of NO Fed rate cuts in 2026 ($7.3M traded volume), with US recession odds by end-2026 priced at only 8% (soft-landing narrative intact). NVDA Q2 beat odds at 97% (Polymarket), suggesting strong AI demand consensus. Rising yields and restrictive Fed policy are headwinds for long-duration growth equities including semis, but intact soft-landing supports WFE capex.